Quality Improvement for Drug Courts: Evidence-Based Practices--Chapters 3 and 4

About the Course:

This monograph presents a general overview of the research on effectively treating the drug court client. It also elucidates the kinds of issues that a drug court administrator and supervisor should consider in developing Request for Proposals for treatment services and identifying additional resources to better serve drug court participants. Focusing on quality improvement in order to better engage, retain, and graduate more clients in the drug court process requires understanding and utilizing the evidence and research. This course covers Chapters 3 and the 4 and addresses the topics of relapse prevention therapy with substance abusing offenders and medication-assisted treatment for participants in drug court programs. This course covers adobe pages 31-50.

Journal/Publisher:

National Drug Court Institute

Publication Date:

April 2008

Authors

Kathryn A. Kelly, B.A.; Charles R. Schuster, Ph.D.; Charles O'Brien, M.D., Ph.D.; G. Alan Marlatt, Ph.D., and George A. Parks, Ph.D.

About the Authors:

Kathryn A. Kelly, B.A., is associated with the FASD Legal Issues Resource Center, University of Washington.

Charles R. Schuster, Ph.D., is associated with the Neuroscience Institute, Loyola University, Chicago.

Charles O’Brien, M.D., Ph.D., is associated with the University of Pennsylvania/VA Medical Center.

G. Alan Marlatt, Ph.D., and George A. Parks, Ph.D., are associated with the Addictive Behaviors Research Center, University of Washington.

Recommended For:

This course is recommended for health care professionals, especially addiction counselors, psychologists, mental health counselors, social workers, and nurses who seek knowledge about relapse prevention therapy with substance abusing offenders and medication-assisted treatment for participants in drug court programs. It is appropriate for all levels of participants’ knowledge.

Course Objectives:

  1. Discuss relapse prevention therapy with substance abusing offenders, including a cognitive-behavioral model of the relapse process and common relapse set-ups.

  2. Describe the evidence supporting the efficacy of relapse prevention therapy and discuss relapse prevention therapy in special populations.

  3. Identify medications used for the treatment of withdrawal signs and symptoms, medications for preventing relapse, and pharmacotherapy for opioid addiction.

Exam Questions

All exam questions for the course are visible on this page for members of Addiction Counselor CE.

Membership is free, and you can sign up today! You'll only pay when you're ready to purchase a course.

If you're already a member, please login to see the exam questions for this and all other courses.

Exam-related Actions